SASE:4013

Stock Analysis Report

NOT FOR DISTRIBUTION
Header cover image

Dr. Sulaiman Al Habib Medical Services Group

Market Cap

ر.س60.0b

Last Updated

2021/08/01 16:13 UTC

Data Sources

Company Financials +

Executive Summary

Dr. Sulaiman Al Habib Medical Services Group Company develops, owns, and operates hospitals and medical centers. More Details


Snowflake Analysis

Outstanding track record with adequate balance sheet.


Similar Companies

Share Price & News

How has Dr. Sulaiman Al Habib Medical Services Group's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 4013 is not significantly more volatile than the rest of SA stocks over the past 3 months, typically moving +/- 3% a week.

Volatility Over Time: 4013's weekly volatility (3%) has been stable over the past year.


Market Performance


7 Day Return

5.5%

4013

3.5%

SA Healthcare

0.2%

SA Market


1 Year Return

96.6%

4013

80.7%

SA Healthcare

15.0%

SA Market

Return vs Industry: 4013 exceeded the SA Healthcare industry which returned 79% over the past year.

Return vs Market: 4013 exceeded the SA Market which returned 15.1% over the past year.


Shareholder returns

4013IndustryMarket
7 Day5.5%3.5%0.2%
30 Day7.7%5.5%-0.2%
90 Day14.7%12.1%0.6%
1 Year100.6%96.6%83.7%80.7%19.4%15.0%
3 Yearn/a62.5%55.6%43.9%31.1%
5 Yearn/a53.9%41.5%106.6%75.7%

Long-Term Price Volatility Vs. Market

How volatile is Dr. Sulaiman Al Habib Medical Services Group's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Dr. Sulaiman Al Habib Medical Services Group undervalued compared to its fair value and its price relative to the market?

53.68x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 4013 (SAR173) is trading above our estimate of fair value (SAR104.78)

Significantly Below Fair Value: 4013 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 4013 is poor value based on its PE Ratio (53.7x) compared to the SA Healthcare industry average (42x).

PE vs Market: 4013 is poor value based on its PE Ratio (53.7x) compared to the SA market (33.8x).


Price to Earnings Growth Ratio

PEG Ratio: 4013 is poor value based on its PEG Ratio (8.4x)


Price to Book Ratio

PB vs Industry: 4013 is overvalued based on its PB Ratio (12.1x) compared to the SA Healthcare industry average (2.9x).


Future Growth

How is Dr. Sulaiman Al Habib Medical Services Group forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

6.4%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 4013's forecast earnings growth (6.4% per year) is below the savings rate (8.8%).

Earnings vs Market: 4013's earnings (6.4% per year) are forecast to grow slower than the SA market (6.7% per year).

High Growth Earnings: 4013's earnings are forecast to grow, but not significantly.

Revenue vs Market: 4013's revenue (10.4% per year) is forecast to grow faster than the SA market (3.2% per year).

High Growth Revenue: 4013's revenue (10.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 4013's Return on Equity is forecast to be high in 3 years time (25.4%)


Past Performance

How has Dr. Sulaiman Al Habib Medical Services Group performed over the past 5 years?

5.7%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 4013 has high quality earnings.

Growing Profit Margin: 4013's current net profit margins (18.2%) are higher than last year (17.2%).


Past Earnings Growth Analysis

Earnings Trend: 4013's earnings have grown by 5.7% per year over the past 5 years.

Accelerating Growth: 4013's earnings growth over the past year (27.8%) exceeds its 5-year average (5.7% per year).

Earnings vs Industry: 4013 earnings growth over the past year (27.8%) exceeded the Healthcare industry 23.8%.


Return on Equity

High ROE: 4013's Return on Equity (21.5%) is considered high.


Financial Health

How is Dr. Sulaiman Al Habib Medical Services Group's financial position?


Financial Position Analysis

Short Term Liabilities: 4013's short term assets (SAR4.2B) exceed its short term liabilities (SAR1.9B).

Long Term Liabilities: 4013's short term assets (SAR4.2B) exceed its long term liabilities (SAR2.8B).


Debt to Equity History and Analysis

Debt Level: 4013's debt to equity ratio (46.2%) is considered high.

Reducing Debt: 4013's debt to equity ratio has increased from 25.1% to 46.2% over the past 5 years.

Debt Coverage: 4013's debt is well covered by operating cash flow (88.7%).

Interest Coverage: 4013's interest payments on its debt are well covered by EBIT (37.8x coverage).


Balance Sheet


Dividend

What is Dr. Sulaiman Al Habib Medical Services Group current dividend yield, its reliability and sustainability?

1.21%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: 4013's dividend (1.21%) isn’t notable compared to the bottom 25% of dividend payers in the SA market (1.45%).

High Dividend: 4013's dividend (1.21%) is low compared to the top 25% of dividend payers in the SA market (4.14%).


Stability and Growth of Payments

Stable Dividend: Too early to tell whether 4013's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if 4013's dividend payments are increasing as they only just started paying a dividend.


Current Payout to Shareholders

Dividend Coverage: With its reasonable payout ratio (71.4%), 4013's dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: 4013's dividends in 3 years are forecast to be covered by earnings (63.9% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.6yrs

Average board tenure


CEO

Nasser Mohammed Al Huqbani

no data

Tenure

ر.س209,000

Compensation

Mr. Nasser Mohammed Abdulaziz Al Huqbani has been Chief Executive Officer and Executive member of Board at Dr. Sulaiman Al Habib Medical Services Group Company since December 10, 2018. Mr. Al Huqbani is a ...


Board Members

Experienced Board: 4013's board of directors are not considered experienced ( 2.6 years average tenure), which suggests a new board.


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Insufficient data to determine if shareholders have been diluted in the past year.


Top Shareholders

Company Information

Dr. Sulaiman Al Habib Medical Services Group Company's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Dr. Sulaiman Al Habib Medical Services Group Company
  • Ticker: 4013
  • Exchange: SASE
  • Founded: 1995
  • Industry: Health Care Facilities
  • Sector: Healthcare
  • Market Cap: ر.س59.990b
  • Shares outstanding: 350.00m
  • Website: https://www.hmg.com

Number of Employees


Location

  • Dr. Sulaiman Al Habib Medical Services Group Company
  • King Fahad Road
  • Olaya District
  • Riyadh
  • 11643
  • Saudi Arabia

Listings


Biography

Dr. Sulaiman Al Habib Medical Services Group Company develops, owns, and operates hospitals and medical centers. The company operates spinal surgery, vascular, general medicine, urology, dental, diabetes a...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/08/01 16:13
End of Day Share Price2021/08/01 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.